Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous AMSCs plus PRP for Knee Osteoarthritis
NCT04212728Phase 2Unknown
- Sponsor
- Yantai Yuhuangding Hospital
- Start
- Dec 2019
- Primary completion
- Dec 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous adipose-derived mesenchymal stromal cells in knee osteoarthritis (OA), sponsored by Yantai Yuhuangding Hospital. Status: unknown.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04212728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04212728.